[1]
“Long-Standing Parkinson’s Disease with Severe Dyskinesia and Response to Clozapine”, Int. j. appl. clin. res., vol. 2, no. 2, pp. 7–9, Jun. 2024, doi: 10.66222/jjbk1j61.